A multicenter study of adjuvant radiotherapy for early endometrial carcinoma

Conditions

Endometrial carcinoma

Wenhui Wang, Tiejun Wang, Zi Liu, Jianli He, Xiaoge Sun et al. (16 authors)

BMC Women s Health2023-08-081 citations

Age ≥60 y May Not be an Appropriate Adverse Risk Factor in Adjuvant Treatment of Patients With Early-Stage Endometrial Carcinoma: A Multi-Institutional Analysis in China.

Sun S, Zou L, Wang T, Liu Z, He J, Sun X, Zhong W, Zhao F, Li X, Li S, Zhu H, Ma Z, Wang W, Meng J, Zhang F, Hou X, Wei L, Hu K.

2021-11-01

10.1016/j.ijrobp.2021.07.1681

Interventions

Case series:Nil

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Pathological diagnosis of endometrial carcinoma, the initial treatment is surgery; 2. Stage I-II (Stage2009, except IaG1 without any risk factors, risk factors including age >60 years old, lymphatic vessel space invasion (LVSI+).the tumor was more than 2cm.the lower uterine segment or cervix was invaded; 3. Initial treatment; 4. Patients treated before 12/31/2015.

Exclusion criteria

Exclusion criteria: 1. Without pathological diagnosis; 2. Recurrent cases or non-initial treatment; 3. Loss to follow-up after treatment; 4. Missing or incomplete data.

Design outcomes

Primary

Measure	Time frame
Overall survival;Progression-free survival;Local recurrence;Distant metastasis;Prognosis;	—

Countries

China

Contacts

Public ContactZHANG FUQUAN

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences

zhangfuquan3@sina.com+86 13311360431

Outcome results

None listed